AI assistant
Dabur India Ltd. — Interim / Quarterly Report 2020
Jan 30, 2020
59077_rns_2020-01-30_a5c201cf-a583-46ed-ad76-b91770091f33.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer

Date: January 30, 2020
Scrip Symbol: NSE- DABUR, BSE Scrip Code: 500096
To, Corporate Relation Department BSE Ltd. Phiroze Jeejeebhoy Towers Dalal Street, Mumbai- 400001
National Stock Exchange of India Ltd. Exchange Plaza, 5th Floor Plot No. C/l, G Block Bandra - Kurla Complex Bandra (E), Mumbai - 400051
Sub: Investors Communication
Dear Sir,
In compliance ofSEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to enclose a copy of Investors Communication being issued by the company today for your records.
This is for your information and records.
Thanking You,
Yours faithfully,
For Dabur India Limited
Executn/e V P (Finance) and Company Secretary
End: as above

Investor Presentation
Q3 FY20
THE SCIENCE OF
30th January 2020
Agenda

Q3 FY20 – Performance Summary

Q3 FY20 – Consolidated Financials

- India FMCG business grew by 5.6% in both value and volume
- International Business grew by 12% on CC basis

- Consol Material cost reduced by 80 bps to touch 49.9% in Q3 FY20
- Media expenditure was at 8.6% in Q3 FY20 vs 8.1% in Q3 FY19 – growing by 14.3%
- Consolidated Operating Margin improved by 70 bps, reaching 20.9% in Q3 FY20

- Consolidated PAT increased by 8.7%
- Before exceptional the growth in PAT was 12.8%
- Consol PAT margin improved by 26 bps to touch 16.9%
Q3 FY20 – Business Overview

- Contribution of Domestic FMCG reduced from 72.2% to 71.1%
- International Business contributed 26.1% as compared to 25.0% last year
Agenda

Domestic FMCG Growth – By Verticals – Q3 FY20

Domestic FMCG Business (excluding Foods) grew by 7% in volume terms
Healthcare (HC) – Q3 FY20
| Health Supplements |
Digestives | OTC | Ethicals | |
|---|---|---|---|---|
| Growth % | 12.2% | 15.9% | 5.5% | 2.7% |
| Category Highlights |
Strong double-digit • growth in Chyawanprash • Dabur's market share in Chyawanprash category increased by ~314 bps |
Driven by continued • strong performance of Hajmola tablets • Pudin Hara Lemon Fizz reported strong double digit growth |
Strong growth in • Honitus brand • High base growth of 17.7% for OTC |
Ethicals' performance • was relatively muted on account of high base growth of 17.4% in Q3 FY19 YTD growth of 7.6% • indicative of underlying growth |

Dabur Chyawanprash – Changing Weather TVC

Honitus - Metro Station Branding in

Home & Personal Care (HPC) – Q3 FY20
| Oral Care | Hair Oils | Shampoo & Post Wash |
Home Care | Skin & Salon | |
|---|---|---|---|---|---|
| Growth % | 8.5% | 0.4% | 5.1% | 2.5% | (0.3%) |
| Category Highlights |
• Red Toothpaste grew by 9.5% • Babool Franchise reported 5% growth Lal Dant Manjan • grew by 10.4% Market share in • toothpastes improved by ~30 bps |
• Growth impacted by category slow down • Market share in hair oils increased by ~50 bps Sarson Amla and • Brahmi Amla recorded double digit growth |
• Vatika Shampoo bottles growing in double digits – bottles saliency going up • Market share in shampoo category increased by ~60 bps |
• Strong growth in Odomos with gain in market share Odonil Aerosols • reported strong growth |
• Skin Care was relatively muted on account of consumption slowdown and high base growth of 19.3% |

Babool Ayurvedic – New TVC

9

Dabur Red – New TVC Dabur Amla – World's No. 1 Hair Oil
Foods – Q3 FY20
| Foods | |||||||
|---|---|---|---|---|---|---|---|
| Growth % | (1.7%) | ||||||
| Category Highlights |
• As per Nielsen, J&N category declined by 11.6% (in volume) in Q3 due to downtrading to lower priced alternatives • Excluding Diwali Gift Packs, Real fruit juices grew by ~5%. Diwali Gift Packs were impacted by the shift in Diwali this year (from Nov in 2018 to Oct in 2019) • Real Activ grew by 17% on the back of strong growth in Activ Coconut Water and institutional business Market share of Real Fruit Juices increased by 530 bps to touch 62.4% • |
||||||
| Culinary business under Hommade brand reported strong double-digit growth • |
|||||||
| Real Activ Coconut Water – Digital |
|||||||
| Real – | Diwali Gift Packs | Campaign 10 |
Hommade – Digital Campaign |
Agenda

Consumer/ Marketing Initiatives – Healthcare

Consumer/ Marketing Initiatives – Healthcare


Ethicals portfolio – 45 vaid meets covering 2,000 vaids Mega Health Camp for Bhopal Gas Tragedy Victims



Consumer/ Marketing Initiatives – Home & Personal Care


Dabur Amla – Savdhaan Campaign Oxylife – Salon Workshop in Towns

Meswak - New TVC Star Screen Awards Sponsorship by Babool and Fem

Consumer/ Marketing Initiatives – Foods

Agenda

Hajmola Chatpati Hing


Odonil Aerosol - Floral Bliss and Ocean Breeze
Bring home
2 New Exotic Fragrances
Odonil
Floral Bliss | Ocean Breeze

Real Aloe Vera Kiwi

Arshoghani Vati

Agenda

International Business – Q3 FY20
• International Business reported CC growth of
12.0%
- MENA market clocked 10.1% CC growth in this quarter
- Egypt recorded growth of 17.0%
- Hobby had a strong quarter, growing by 32.2%
- Namaste business reported 9.8% growth with a strong
performance in the international business
• Nepal business increased by 20.6%
Q3 FY20 Constant Currency Growth %

Product Launches – International Business

Consumer/ Marketing Initiatives – International Business


Consolidated Profit & Loss Statements
| figures All are in INR cr |
Q3 FY20 | Q3 FY19 | Y-o-Y (%) | 9M FY20 | 9M FY19 | Y-o-Y (%) |
|---|---|---|---|---|---|---|
| Revenue from operations | 2,353.0 | 2,199.2 | 7.0% | 6,838.2 | 6,404.9 | 6.8% |
| Other Income | 74.5 | 75.3 | (1.0%) | 229.5 | 230.1 | (0.3%) |
| Total Income | 2,427.4 | 2,274.5 | 6.7% | 7,067.75 | 6,634.97 | 6.5% |
| Material Cost | 1,174.4 | 1,115.3 | 5.3% | 3,410.6 | 3,239.7 | 5.3% |
| of % Revenue |
49 9% |
50 7% |
49 9% |
50 6% |
||
| Employee expense | 244.8 | 237.6 | 3.0% | 717.7 | 696.0 | 3.1% |
| of % Revenue |
10 4% |
10 8% |
10 5% |
10 9% |
||
| Advertisement and publicity | 203.5 | 178.1 | 14.3% | 549.8 | 510.6 | 7.7% |
| % of Revenue |
8 6% |
8 1% |
8 0% |
8 0% |
||
| Other Expenses | 237.4 | 222.9 | 6.5% | 720.1 | 676.2 | 6.5% |
| of % Revenue |
10 1% |
10 1% |
10 5% |
10 6% |
||
| Operating Profit | 492.9 | 445.4 | 10.7% | 1,440.1 | 1,282.3 | 12.3% |
| % of Revenue |
20 9% |
20 3% |
21 1% |
20 0% |
||
| EBITDA | 567.4 | 520.6 | 9.0% | 1,669.6 | 1,512.5 | 10.4% |
| of % Revenue |
24 1% |
23 7% |
24 4% |
23 6% |
||
| Finance Costs | 10.5 | 16.7 | (37.4%) | 41.0 | 47.2 | (13.2%) |
| Depreciation & Amortization | 54.4 | 44.9 | 21.3% | 161.6 | 130.7 | 23.7% |
| Profit before exceptional items, tax and share of profit/(loss) from joint venture |
502.5 | 459.1 | 9.5% | 1,467.0 | 1,334.6 | 9.9% |
| % of Revenue |
21 4% |
20 9% |
21 5% |
20 8% |
||
| Share of profit / (loss) of joint venture | (0.2) | 0.5 | (128.8%) | 0.4 | 1.0 | (62.4%) |
| Exceptional item(s) | 20.0 | 0.0 | n.a. | 80.0 | 0.0 | n.a. |
| Tax Expenses | 83.5 | 92.4 | (9.6%) | 221.1 | 260.8 | (15.2%) |
| Net profit after tax and after share of profit/(loss) from joint venture |
398.9 | 367.2 | 8.6% | 1,166.3 | 1,074.8 | 8.5% |
| of % Revenue |
17 0% |
16 7% |
17 1% |
16 8% |
||
| Non controlling interest | 1.2 | 1.2 | 0.9% | 2.5 | 2.9 | (11.5%) |
| Net profit for the period/year | 397.7 | 366.1 | 8.7% | 1,163.8 | 1,071.9 | 8.6% |
| of % Revenue |
16 9% |
16 6% |
17 0% |
16 7% |
Standalone Profit & Loss Statements
| figures All are in INR cr |
Q3 FY20 | Q3 FY19 | Y-o-Y (%) | 9M FY20 | 9M FY19 | Y-o-Y (%) |
|---|---|---|---|---|---|---|
| Revenue from operations | 1,748.2 | 1,664.5 | 5.0% | 4,988.6 | 4,674.8 | 6.7% |
| Other Income | 67.3 | 67.4 | (0.1%) | 209.9 | 211.7 | (0.9%) |
| Total Income | 1,815.4 | 1,731.8 | 4.8% | 5,198.50 | 4,886.45 | 6.4% |
| Material Cost | 895.1 | 863.9 | 3.6% | 2,568.10 | 2,436.99 | 5.4% |
| of % Revenue |
51 2% |
51 9% |
51 5% |
52 1% |
||
| Employee expense | 149.7 | 147.9 | 1.2% | 444.7 | 429.1 | 3.6% |
| % of Revenue |
8 6% |
8 9% |
8 9% |
9 2% |
||
| Advertisement and publicity | 166.3 | 147.0 | 13.1% | 445.1 | 413.8 | 7.6% |
| of % Revenue |
9 5% |
8 8% |
8 9% |
8 9% |
||
| Other Expenses | 145.5 | 140.2 | 3.8% | 448.1 | 421.3 | 6.4% |
| % of Revenue |
8 3% |
8 4% |
9 0% |
9 0% |
||
| Operating Profit | 391.6 | 365.5 | 7.1% | 1,082.7 | 973.5 | 11.2% |
| of % Revenue |
22 4% |
22 0% |
21 7% |
20 8% |
||
| EBITDA | 458.8 | 432.9 | 6.0% | 1,292.5 | 1,185.2 | 9.1% |
| of % Revenue |
26 2% |
26 0% |
25 9% |
25 4% |
||
| Finance Costs | 4.7 | 9.5 | (51.3%) | 16.6 | 23.5 | (29.2%) |
| Depreciation & Amortization | 32.6 | 28.0 | 16.7% | 96.8 | 80.2 | 20.7% |
| Profit before exceptional items, tax and share of profit/(loss) from joint venture |
421.5 | 395.4 | 6.6% | 1,179.14 | 1,081.52 | 9.0% |
| of % Revenue |
24 1% |
23 8% |
23 6% |
23 1% |
||
| Exceptional item(s) | 20.0 | 0.0 | n.a. | 80.0 | 0.0 | n.a. |
| Tax Expenses | 71.5 | 83.2 | (14.1%) | 185.8 | 231.5 | (19.8%) |
| Net profit for the period/year | 330.0 | 312.1 | 5.7% | 913.3 | 850.0 | 7.5% |
| of % Revenue |
18 9% |
18 8% |
18 3% |
18 2% |



Get Fast Relief with Dabur Honitus.
As per AC Nielsen RMS Dec'2018 data

For more information & updates, visit : http://www.dabur.com/in/en-us/investor